Posted by Gary Schwitzer in Disease mongering
Because this project lost its foundation funding on July 1, 2013, the publisher is unable to pay any of the terrific reviewers pictured at upper right on this page. We hope this is only a temporary situation as we continue to pursue other funding sources. Meantime, the publisher will continue to write frequently on the Health News Watchdog blog on this site.
Thank you for your continued interest.
It’s difficult to do an overview of melanoma drug research in a relatively brief story. But this story did a solid job.
Better than a competing piece by Reuters but still a little short on some details about this asthma drug study.
We will not display your name or e-mail address on the site, nor will we share youre-mail address with any third parties.
Copyright © 2014 Health News Review